In situ and intraductal epithelial proliferations of prostate: definitions and treatment implications. Part 2: intraductal carcinoma and ductal adenocarcinoma of prostate

BJU Int. 2012 Dec:110 Suppl 4:22-4. doi: 10.1111/j.1464-410X.2012.11612.x.

Abstract

• High-grade prostatic intraepithelial neoplasia (HGPIN) is an intracellular proliferation of ductal epithelial cells. On its own, the presence of HGPIN does not warrant active intervention. • In contrast, intraductal carcinoma of prostate and prostatic ductal adenocarcinoma of prostate are markers of aggressive prostatic adenocarcinoma. • The presence of even small foci of these tumours on biopsy warrants immediate intervention, even in the absence of demonstrable invasive disease. • This second part of the review of in situ epithelial proliferations of the prostate looks at these conditions in more detail.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma, Mucinous / diagnostic imaging
  • Adenocarcinoma, Mucinous / pathology
  • Adenocarcinoma, Mucinous / therapy*
  • Biopsy, Fine-Needle
  • Biopsy, Needle
  • Carcinoma, Ductal / diagnostic imaging
  • Carcinoma, Ductal / pathology
  • Carcinoma, Ductal / therapy*
  • Cell Proliferation
  • Combined Modality Therapy
  • Diagnosis, Differential
  • Disease Progression
  • Endosonography
  • Humans
  • Male
  • Neoplasm Staging
  • Prostatic Intraepithelial Neoplasia / diagnostic imaging
  • Prostatic Intraepithelial Neoplasia / pathology
  • Prostatic Intraepithelial Neoplasia / therapy*
  • Prostatic Neoplasms / diagnostic imaging
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / therapy*
  • Urethra